Pure Extracts Technologies Corp. — Capital/Financing Update 2022

Jul 6, 2022

Form 51-102F3 MATERIAL CHANGE REPORT

Item 1 Name and Address of Company

Pure Extracts Technologies Corp. (the “ Company ”) 7341 Industrial Way, Unit 6 Pemberton, BC V0N 2K0

Item 2 Date of Material Change June 22, 2022

• Item 3 News Release

The Company disseminated a news release dated June 22, 2022 through Global Newswire and a copy was subsequently filed on SEDAR.

Item 4 Summary of Material Change

Pure Extracts Technologies Corp. (the “Company”) a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has entered into a one year credit agreement (the “ Credit Agreement ”) with Pivot Financial I Limited Partnership (“ Pivot ”) for a non-revolving term loan in the aggregate amount of $1,225,000 (the “ Credit Facility ”).

Item 5 Full Description of Material Change

5.1 Full Description of Material Change

The Issuer announced that it has entered into a one year credit agreement (the “ Credit Agreement ”) with Pivot Financial I Limited Partnership (“ Pivot ”) for a non-revolving term loan in the aggregate amount of $1,225,000 (the “ Credit Facility ”).

In connection with the Credit Facility, Pure Extracts has entered into a general security agreement in favour of Pivot on terms and conditions customary in such transactions. The Credit Facility shall be used by Pure Extracts for: (i) re-financing 2 equipment leases, (ii) the purchase of biomass for extraction, (iii) building finished product inventory, and (iv) general working capital purposes.

5.2 Disclosure for Restructuring Transactions

Not applicable.

Item	6	Reliance on subsection 7.1(2) of National Instrument 51-102
		Not applicable.
Item	7	Omitted Information
		No information has been omitted on the basis that it is confidential information.
Item	8	Executive Officer
		Ben Nikolaevsky, CEO & Director,
		Tel: +1 (604) 343-2724
Item	9	Date of Report
		July 5, 2022
		Cautionary Note Regarding Forward-Looking Information

This material change report contains certain forward-looking information, including about the proposed use of proceeds of the Offering, the filing of a Prospectus Supplement, and the receipt of CSE approval. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forwardlooking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this material change report. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.